LAA occlusion - Between belief and evidence

26 August 2018 (12:12 - 12:30)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Michael Glikson

Shaare Zedek Medical Center, Jerusalem (Israel)

3 More presentations in this session

Presentation thumbnail

Stroke prevention in atrial fibrillation - State of the art

Professor J. Steffel (Zurich, CH)

Presentation thumbnail

Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience

Mr J. Komen (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

Doctor M. Kerneis (Paris, FR)

Abstract Slides Video

Access the full session

Session thumbnail

Stroke prevention in atrial fibrillation

The Event

ESC Congress 2018

26 August 2018 12:12 CET

You may be interested in

Congress Presentation

Left atrial appendage closure in atrial fibrillation: gaps in knowledge

1 September 2025

Congress Presentation

Impact of left atrial appendage closure on events after intracranial haemorrhage in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry

1 September 2025

Congress Presentation

Left atrial appendage occlusion indicated by increased thrombotic risk versus increased bleeding risk: a comparison of the stroke despite anticoagulation (STR-OAC) and EWOLUTION cohorts

28 August 2023

Congress Presentation

Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis

4 April 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources